Call us : 855-228-7355

Investor Relations

Agent Benefits 4

Novus Q3 2024: A Strong Quarter Amidst Industry Shifts

A New Frontier: Cannabis Coverage in Health Plans

The Latest:

$NDEV stands out with these key factors driving its recent momentum:

*Political and Regulatory Developments: The federal government’s commitment to cannabis reclassification and banking reform could significantly reduce regulatory pressures on the industry. The upcoming DEA hearing on cannabis rescheduling, scheduled for December 2, 2024, indicates a potential turning point for industry growth. Additionally, federal agencies (Veteran Affairs) are allocating funds for further research, and an increasing number of banks are beginning to transact business within the cannabis sector.

*Sustaining Business Model The potential rescheduling of cannabis represents a crucial turning point for the industry. As regulations evolve, Novus is strategically positioned to take advantage of the broader market opportunities that may arise. Even if interstate commerce or the SAFER Banking Act is not enacted, Novus will be able to sustain its business model.

*Investor and Financial Sector: As banks enter the cannabis sector, these changes may increase investor interest as they prepare to benefit from upcoming federal reforms.

*Growth, Profit, and Reinvestment Strategy: Unlike many cannabis companies that rely on outside funding, Novus doesn’t need external investment for growth. Our strategy focuses on strong revenue and profitability. By reinvesting profits, we remain independent and committed to continuous innovation and market growth.

Quote and Research Links are Below

About Novus:

Since 2015, Novus Acquisition & Development Corporation (NDEV), d/b/a Novus Cannabis MedPlanⓇ, has been a pioneer in integrating THC and CBD cannabis into health insurance plans for both medical and recreational cannabis consumers. With over 1,200 agents, brokers, and dispensaries, NDEV generates revenue through insurance premiums and provides policyholders access to affordable treatment options. 

The company’s niche is offering cannabis as an alternative to opioids and protecting veterans from VA benefit denials due to participation in state-approved cannabis programs. NDEV’s sustainability is based on its receivable-based business model. It has attracted interest from major carriers and InsurTech platforms for future plan integration..

Cap Structure

As of June 1, 2024
Authorized Shares:200 million
Outstanding Shares:107,803,624
Float:30,948,730
Par Value:$0.001
Restricted Shares:76,854,894
Research With Your 
Adviser
  

Due Diligence Review

Quote: Click Here
Press Releases: Click Here
Filings: Click Here
Pitch Deck: Click Here
Investment Highlights Video: Click Here
Disclaimer and Forward-Looking Statement Click Here

Contact Us

* Indicates Required Field

855-228-7355

We are available Monday - Friday 9:00 am - 5:00 pm (EST) Email: info@getnovusnow.com

  • follow us on
  • Novus Cannabis MedPlan